Diabetes
From the Journals
Cold water immersion can have benefits
Immersion in cold water has a major impact on the body.
From the Journals
Diabetes decision tool yields ‘modest’ benefit in low-resource clinics
Another positive of this tool is that it could curtail physician burnout, authors of new research say.
News
With type 1 diabetes delay possible, focus now on screening
The FDA approval of teplizumab for the delay of type 1 diabetes highlights the need to cost effectively identify those at risk who could...
Feature
Medical school culinary medicine programs grow despite limited funding
As part of Dr. Marvasti’s program, students learn cooking fundamentals through chef demonstrations and hands-on practice – to teach students how...
News from the FDA/CDC
FDA approves first-ever agent to delay type 1 diabetes onset
Teplizumab delayed progression to clinical type 1 diabetes by about 2 years compared with placebo in individuals destined to develop the condition...
Conference Coverage
Does COVID-19 cause type 1 diabetes in children? Time will tell
Norwegian study finds association of SARS-CoV-2 with type 1 diabetes if diagnosed over 30 days after infection, while Scottish study finds no such...
Commentary
The bionic pancreas triumphs in pivotal trial
When it comes to closed-loops systems for insulin delivery for type 1 diabetes, easier might be better. A new report on such a “bionic pancreas”...
Livin' on the MDedge
Early bird gets the worm, night owl gets the diabetes
Plus: Sweating for mosquito science, sharing genes with zebrafish, and sharing vomit with synanthropic flies.
Conference Coverage
Could exercise improve bone health in youth with type 1 diabetes?
“This study suggests that bone-loading physical activity can substantially improve skeletal health in children with” type 1 diabetes.
Feature
How do you live with COVID? One doctor’s personal experience
Early in 2020, Anne Peters, MD, caught COVID-19. The author of Medscape’s “Peters on Diabetes” column was sick in March 2020 before state-mandated...
News
FDA clears tubeless, automated insulin system for children age 2 and older
The Food and Drug Administration has approved use of the Omnipod 5 automated insulin delivery system for kids age 2 and older with type 1 diabetes...